Inositol 1,3,4,5,6-pentakisphosphate 2-kinase pseudogene 1 (IPPKP1)

**Inositol 1,3,4,5,6-pentakisphosphate 2-kinase pseudogene 1** does not correspond to a known functional protein, receptor, enzyme, or therapeutic target in curated databases or the scientific literature. It appears to be inaccurately named or derived from confusion with functional kinases involved in inositol phosphate metabolism, such as **Inositol 1,3,4,5,6-pentakisphosphate 2-kinase** (IPPK, also referenced as IP5 2-K), an enzyme responsible for the phosphorylation of inositol pentakisphosphate to inositol hexakisphosphate (phytate), which has diverse roles in cell biology including DNA repair, RNA metabolism, vesicle trafficking, and apoptosis[5][7]. However, the addition of "pseudogene 1" indicates this entity is a nonfunctional genomic sequence, not a canonical therapeutic target, and there is no evidence in major databases (GeneCards, UniProt, NCBI Gene) for a canonical IPPKP1 gene or protein in humans[6]. Pseudogenes may have regulatory roles at the RNA level, but no such function is established here. There is also no evidence this pseudogene is involved in disease, mechanism of drug action, or is a biomarker. The functional enzyme (IPPK) is classified as an **enzyme** (kinase), but the pseudogene is not a member of any molecular or therapeutic classification relevant to drug targets. Summary of error/correction: - **"is_incorrect: true"** is set because IPPKP1 is not a recognized or validated drug target, protein, or receptor, and likely represents either a misnaming or a genomic annotation artifact; it is not listed in any authoritative human gene or protein database with known functional or therapeutic relevance[6].

Other names

Inositol 1,3,4,5,6-pentakisphosphate 2-kinase pseudogeneIPPKP1 (genomic context, if mapped as such)No established aliases in literature or major databases; not a recognized protein/gene product